SCHEMBL1925893

SCHEMBL1925893

CCCCNC(=O)c1cccc(-c2ccccc2)c1

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.77
NAAA Q02083 1/20 0.65
HDAC1 Q13547 3/20 0.64
HDAC2 Q92769 2/20 0.64
DRD2 P14416 2/20 0.59
DRD4 P21917 2/20 0.59
DRD3 P35462 2/20 0.59
HDAC8 Q9BY41 2/20 0.57
TSHR P16473 1/20 0.57
HTT P42858 1/20 0.57
ALOX15 P16050 1/20 0.56
PPARG P37231 1/20 0.56
PPARA Q07869 1/20 0.56
EPHX2 P34913 1/20 0.56
NR1H4 Q96RI1 1/20 0.56
ERN1 O75460 1/20 0.55
L3MBTL1 Q9Y468 1/20 0.55
HDAC3 O15379 1/20 0.55
NCOR2 Q9Y618 1/20 0.55
F2R P25116 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1927120 0.91 L3MBTL1 (0.67) SMN1; SMN2NAAAHDAC1HDAC2DRD2
SCHEMBL16117373 0.87 SMN1; SMN2 (1.00) SMN1; SMN2NAAAHDAC1HDAC2TSHR
SCHEMBL6360275 0.86 DRD2 (0.78) SMN1; SMN2NAAAHDAC1HDAC2DRD2
SCHEMBL1002854 0.85 NAAA (0.86) SMN1; SMN2NAAAHDAC1HDAC2DRD2
SCHEMBL10242958 0.85 SMN1; SMN2 (0.67) SMN1; SMN2NAAAHDAC1HDAC2TSHR
SCHEMBL13693382 0.84 SMN1; SMN2 (0.87) SMN1; SMN2NAAAHDAC1HDAC2TSHR
SCHEMBL4439622 0.84 HDAC8 (0.64) SMN1; SMN2HDAC1HDAC2HDAC8EPHX2
Bromide SCHEMBL4760760 0.84 NAAA (0.83) SMN1; SMN2NAAAHDAC1HDAC2DRD2
SCHEMBL9503009 0.84 NAAA (0.83) SMN1; SMN2NAAAHDAC1HDAC2DRD2
Hydrochloric Acid SCHEMBL15954598 0.84 NAAA (0.83) SMN1; SMN2NAAAHDAC1HDAC2DRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1763509-B1 ALPHA-HELICAL MIMETICS WALTER & ELIZA HALL INST MEDICAL RES (AU) 2018-02-21 EP disclosed
US-7956216-B2 Benzoyl urea derivatives mimicing BH3-only proteins, able to interact with a Bcl-2 protein THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH (AU) 2011-06-07 US disclosed
US-20080153802-A1 Alpha-helical mimetics THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH (AU) 2008-06-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080153802-A1 Alpha-helical mimetics BID, BAX, BAD SMN1; SMN2 860/4885NAAA 2588/4885HDAC1 1665/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.